Rolipram-induced improvement of cognitive function correlates with changes in hippocampal CREB phosphorylation, BDNF and Arc protein levels

Neuroscience Letters

Volumn 610, Issue , 2016, Pages 171-176

  Zhong, Yuan ^a   Zhu, Yitong ^b   He, Ting ^a   Li, Wei ^a   Yan, Hong ^a   Miao, Ya ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Arc protein; Brain derived neurotrophic factor; CAMP response element binding protein; Cognition; Rolipram

Indexed keywords

ARC PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PHOSPHODIESTERASE IV; ROLIPRAM; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; MUSCLE PROTEIN; NOL3 PROTEIN, RAT; PHOSPHODIESTERASE IV INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MORRIS WATER MAZE TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SPATIAL MEMORY; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; THERAPY EFFECT; WORKING MEMORY; ANIMAL; COGNITION; COGNITION DISORDERS; COMPLICATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; MAZE TEST; METABOLISM; PHOSPHORYLATION; PSYCHOLOGY; SHORT TERM MEMORY; SPATIAL LEARNING; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; COGNITION DISORDERS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MUSCLE PROTEINS; PHOSPHODIESTERASE 4 INHIBITORS; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; ROLIPRAM; SPATIAL LEARNING;

EID: 84947286120     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.09.023     Document Type: Article

References (36)

1. Butterfield D.A., Di Domenico F., Barone E. Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim. Biophys. Acta 2014, 1842:1693-1706.
2. Jones A., Kulozik P., Ostertag A., Herzig S. Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetes. J. Alzheimers Dis. 2009, 16:787-808.
3. Paramanik V., Thakur M.K. Role of CREB signaling in aging brain. Arch. Ital. Biol. 2013, 151:33-42.
4. Qiao F., Gao X.P., Yuan L., Cai H.Y., Qi J.S. Apolipoprotein E4 impairs in vivo hippocampal long-term synaptic plasticity by reducing the phosphorylation of CaMKIIalpha and CREB. J. Alzheimers Dis. 2014, 41:1165-1176.
5. Zhang X., Odom D.T., Koo S.H., Conkright M.D., Canettieri G., et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4459-4464.
6. Bekinschtein P., Cammarota M., Katche C., Slipczuk L., Rossato J.I., et al. BDNF is essential to promote persistence of long-term memory storage. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2711-2716.
7. Korb E., Finkbeiner S. Arc in synaptic plasticity: from gene to behavior. Trends Neurosci. 2011, 34:591-598.
8. Gong B., Vitolo O.V., Trinchese F., Liu S., Shelanski M., et al. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest. 2004, 114:1624-1634.
9. Monti B., Berteotti C., Contestabile A. Subchronic rolipram delivery activates hippocampal CREB and arc, enhances retention and slows down extinction of conditioned fear. Neuropsychopharmacology 2006, 31:278-286.
10. Shi X., Lu X.G., Zhan L.B., Qi X., Liang L.N., et al. The effects of the Chinese medicine ZiBu PiYin recipe on the hippocampus in a rat model of diabetes-associated cognitive decline: a promote analysis. Diabetologia 2011, 54:1888-1899.
11. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 1984, 11:47-60.
12. Cukierman T., Gerstein H.C., Williamson J.D. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005, 48:2460-2469.
13. Yaffe K., Fiocco A.J., Lindquist K., Vittinghoff E., Simonsick E.M., et al. Predictors of maintaining cognitive function in older adults: the Health ABC study. Neurology 2009, 72:2029-2035.
14. Zhang T., Pan B.S., Zhao B., Zhang L.M., Huang Y.L., et al. Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of beta-secretase activation and beta-amyloid generation in rat brains. Neuroscience 2009, 161:1045-1056.
15. Li Y.F., Cheng Y.F., Huang Y., Conti M., Wilson S.P., et al. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling. J. Neurosci. 2011, 31:172-183.
16. Barad M., Bourtchouladze R., Winder D.G., Golan H., Kandel E. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:15020-15025.
17. Li Y.F., Huang Y., Amsdell S.L., Xiao L., O'Donnell J.M., et al. Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 2009, 34:2404-2419.
18. Bekinschtein P., Katche C., Slipczuk L.N., Igaz L.M., Cammarota M., et al. mTOR signaling in the hippocampus is necessary for memory formation. Neurobiol. Learn. Mem. 2007, 87:303-307.
19. Williams C.M., El Mohsen M.A., Vauzour D., Rendeiro C., Butler L.T., et al. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic. Biol. Med. 2008, 45:295-305.
20. Conkright M.D., Guzman E., Flechner L., Su A.I., Hogenesch J.B., et al. Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Mol. Cell 2003, 11:1101-1108.
21. Bramham C.R., Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 2005, 76:99-125.
22. Wang D.C., Chen S.S., Lee Y.C., Chen T.J. Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons. Neurosci. Lett. 2006, 398:78-82.
23. Zhen Y.F., Zhang J., Liu X.Y., Fang H., Tian L.B., et al. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. Psychopharmacology (Berl) 2013, 227:93-100.
24. Plath N., Ohana O., Dammermann B., Errington M.L., Schmitz D., et al. Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 2006, 52:437-444.
25. Guzowski J.F., Lyford G.L., Stevenson G.D., Houston F.P., McGaugh J.L., et al. Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J. Neurosci. 2000, 20:3993-4001.
26. Ginsberg S.D., Hemby S.E., Lee V.M., Eberwine J.H., Trojanowski J.Q. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neurol. 2000, 48:77-87.
27. Wu J., Petralia R.S., Kurushima H., Patel H., Jung M.Y., et al. Arc/Arg3.1 regulates an endosomal pathway essential for activity-dependent beta-amyloid generation. Cell 2011, 147:615-628.
28. Wang K.H., Majewska A., Schummers J., Farley B., Hu C., et al. In vivo two-photon imaging reveals a role of arc in enhancing orientation specificity in visual cortex. Cell 2006, 126:389-402.
29. Chen T.J., Wang D.C., Chen S.S. Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons. J. Neurosci. Res. 2009, 87:2297-2307.
30. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 2004, 24:10191-10200.
31. Palop J.J., Chin J., Bien-Ly N., Massaro C., Yeung B.Z., et al. Vulnerability of dentate granule cells to disruption of arc expression in human amyloid precursor protein transgenic mice. J. Neurosci. 2005, 25:9686-9693.
32. Rudinskiy N., Hawkes J.M., Betensky R.A., Eguchi M., Yamaguchi S., et al. Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease. Nat. Neurosci. 2012, 15:1422-1429.
33. Balasubramanyam A., Nalini R., Hampe C.S., Maldonado M. Syndromes of ketosis-prone diabetes mellitus. Endocr Rev. 2008, 29(May (3)):292-302.
34. Trudeau F., Gagnon S., Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus [J]. Eur. J. Pharmacol. 2004, 490(1):177-186.
35. Morrison J.H., Hof P.R. Life and death of neurons in the aging brain [J]. Science 1997, 278(5337):412-419.
36. Ying S.W., Futter M., Rosenblum K., Webber M.J., Hunt S.P., et al. Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J. Neurosci. 2002, 22:1532-1540.